Gary J. Bridger's most recent trade in X4 Pharmaceuticals Inc was a trade of 45,000 Common Stock done . Disclosure was reported to the exchange on June 10, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
X4 Pharmaceuticals Inc | Gary J. Bridger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 45,000 | 96,667 (0%) | 0% | 0 | Common Stock | |
X4 Pharmaceuticals Inc | Gary J. Bridger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 6,667 | 6,667 (0%) | 0% | 0 | Common Stock | |
X4 Pharmaceuticals Inc | Gary J. Bridger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
X4 Pharmaceuticals Inc | Gary J. Bridger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2020 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
X4 Pharmaceuticals Inc | Gary J. Bridger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 3,427 | 3,427 | - | - | Stock Option (right to buy) |